Jiang Li
About Jiang Li
Jiang Li is the Director at BeiGene with over 15 years of experience in the pharmaceutical industry, specializing in biostatistics.
Current Role at BeiGene
Jiang Li is currently serving as a Director at BeiGene, a role they have held since January 2018. At BeiGene, Jiang leverages over 15 years of experience in the pharmaceutical industry to contribute to various projects and initiatives, particularly in the development of clinical trials and drug development.
Career at Novartis
From 2012 to 2018, Jiang Li worked at Novartis as an Associate Director. Over a span of six years, Jiang assumed leadership responsibilities, aiding in the development and approval of multiple drugs. This experience at a major pharmaceutical company enriched Jiang's proficiency in biostatistics and drug development.
Roles at Roche and Bristol-Myers Squibb
Before joining Novartis, Jiang Li held the position of Statistical Scientist at Roche from 2008 to 2012 and Senior Statistician at Bristol-Myers Squibb from 2006 to 2008. These roles further solidified Jiang's expertise in biostatistics, enhancing their ability to design and analyze clinical trials.
Educational Background in Biostatistics
Jiang Li studied Biostatistics at Boston University, earning a Doctor of Philosophy (Ph.D.). This academic background has been fundamental in Jiang's ability to lead and conduct complex statistical analyses in the pharmaceutical industry, significantly contributing to their success in various roles.
Experience in Pharmaceutical Industry
With over 15 years of experience in the pharmaceutical industry, Jiang Li has demonstrated leadership and expertise at companies such as BeiGene, Novartis, Roche, and Bristol-Myers Squibb. Jiang's strong background in biostatistics has been crucial for the development and approval of multiple drugs across these organizations.